{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T05:29:35Z","timestamp":1676438975266},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":944,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1111\/j.1365-2133.2012.11150.x","type":"journal-article","created":{"date-parts":[[2012,7,14]],"date-time":"2012-07-14T15:25:19Z","timestamp":1342279519000},"page":"448-450","source":"Crossref","is-referenced-by-count":2,"title":["Willingness-to-pay and patient-defined benefits in the treatment of hyperhidrosis: results from the first German health services research study in hyperhidrosis"],"prefix":"10.1093","volume":"168","author":[{"given":"C.","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,1,30]]},"reference":[{"key":"10.1111\/j.1365-2133.2012.11150.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1610-0387.2007.06409.x","article-title":"Definition and treatment of primary hyperhidrosis","volume":"5","author":"Worle","year":"2007","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/j.1365-2133.2012.11150.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaad.2007.01.009","article-title":"Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety","volume":"56","author":"Lowe","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11150.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1365-2133.2004.06317.x","article-title":"The place of botulinum toxin type A in the treatment of focal hyperhidrosis","volume":"151","author":"Lowe","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11150.x-BIB4|cit4","first-page":"870","article-title":"Focal hyperhidrosis: disease characteristics and treatments","volume":"5","author":"Campanelli","year":"2009","journal-title":"Rev Med Suisse"},{"key":"10.1111\/j.1365-2133.2012.11150.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2012.50","article-title":"Willingness to pay in dermatology: assessment of the burden of skin diseases","volume":"132","author":"Seidler","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11150.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2133.2009.09091.x","article-title":"Willingness-to-pay and quality of life in patients with vitiligo","volume":"161","author":"Radtke","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11150.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10227-002-0145-y","article-title":"The importance of skin disease as assessed by \u2018willingness-to-pay\u2019","volume":"7","author":"Parks","year":"2003","journal-title":"J Cutan Med Surg"},{"key":"10.1111\/j.1365-2133.2012.11150.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00403-009-0928-8","article-title":"The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases","volume":"301","author":"Augustin","year":"2009","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1365-2133.2012.11150.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1365-2133.2009.09328.x","article-title":"Measuring patient-relevant benefits in pruritus treatment: development and validation of a specific outcomes tool","volume":"161","author":"Blome","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11150.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000128992","article-title":"Benefit evaluation in vitiligo treatment: development and validation of a patient-defined outcome questionnaire","volume":"217","author":"Augustin","year":"2008","journal-title":"Dermatology"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2012.11150.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2012.11150.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:56:44Z","timestamp":1676383004000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/168\/2\/448\/6614338"}},"subtitle":["Correspondence"],"short-title":[],"issued":{"date-parts":[[2013,1,30]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2012.11150.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1,30]]}}}